Low-grade @entity6019 ( @entity6019 ) is a kind of uterine @entity5 . Total hysterectomy and bilateral salpingo-oophorectomy was the main treatment. We evaluate the feasibility of fertility-sparing management in five @entity1 with low-grade @entity6019 who desired for childbearing. The @entity1 aged 28-36 years old presented with symptoms of menometrorrhagia or without symptom. Ultrasound examinations demonstrated @entity2909 (with the diameter of 3.5-6 cm respectively). All the @entity1 received conservative surgeries of local resection of the mass with uterine reconstruction. Then the adjuvant endocrine therapy was given to them with @entity6303 (160-320 mg/day) or @entity19040 (3.75 mg/28 days) for 5-6 months. The follow-up lasted 21-55 months. All the @entity1 survived. Three of them underwent an uncomplicated pregnancy, and received cesarean delivery of a liveborn neonate. One of them is alive without disease recurrence. The other one found disease recurred during the @entity6303 treatment, and received hysterectomy. We consider that fertility-sparing treatment is suitable in selected in young low-grade @entity6019 @entity1 especially for those whose lesion was with a clear borderline. Adjuvant endocrine therapy is recommended for about 6 months after operation.

Fertility-sparing treatment of low-grade XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity19040 :: ('MESH:D017329', 'Chemical') :: ['triptorelin'] @entity5 :: ('MESH:D009369', 'Disease') :: ['malignancy'] @entity6019 :: ('MESH:D018203', 'Disease') :: ['endometrial stromal sarcoma', 'ESS'] @entity6303 :: ('MESH:D019290', 'Chemical') :: ['megestrol acetate'] @entity2909 :: ('MESH:D007889', 'Disease') :: ['leiomyomas']
@entity6019 :: (MESH:D018203,Disease) :: ['endometrial stromal sarcoma']
